SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire January 05, 2026 LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Skye Bioscience, Inc. (“Skye” or “the Company”) (NASDAQ: […]

Daniel Marcus Appointed to Cambridge Atomworks' Advisory Board GlobeNewswire January 05, 2026 CAMBRIDGE, United Kingdom, Jan. 05, 2026 (GLOBE NEWSWIRE) — Daniel Marcus will be joining Cambridge Atomworks' Advisory Board to offer business strategy, legal and financial advice. Dan leads MarcX, a business consultancy providing strategic advice and practical solutions to clients across the financial

Portnoy Law Firm Announces Class Action on Behalf of SLM Corporation a/k/a Sallie Mae Investors GlobeNewswire January 05, 2026 LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises SLM Corporation a/k/a Sallie Mae, (“SLM” or the “Company”) (NASDAQ: SLM, SLMBP) investors off a class action on behalf of investors that bought

LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises NowRX, Inc., (“NowRX” or the “Company”) investors of a class action on behalf of investors that bought securities between February 1, 2022 and November 5, 2022, inclusive (the “Class Period”). NowRX investors have until January 23, 2026 to file a lead plaintiff

(NYSE:OWL), LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Blue Owl Capital, Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) investors of a class action on behalf of investors that bought securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”). Blue Owl investors have until February

Portnoy Law Firm Announces Class Action on Behalf of NowRX, Inc. Investors GlobeNewswire January 05, 2026 LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises NowRX, Inc., (“NowRX” or the “Company”) investors of a class action on behalf of investors that bought securities between February 1, 2022 and November 5, 2022,

Portnoy Law Firm Announces Class Action on Behalf of Blue Owl Capital, Inc Investors GlobeNewswire January 05, 2026 LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Blue Owl Capital, Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) investors of a class action on behalf of investors that bought securities between

(NYSE:ITGR), LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Integer Holdings Corporation, (“Integer” or the “Company”) (NYSE: ITGR) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors. Investors are encouraged to contact attorney Lesley F. Portnoy, by

(NASDAQ:IINN), RA'ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Inspira(TM) Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced it has entered into a non-binding term sheet (the “Term Sheet”), outlining the principal terms of a proposed two-part transaction that would include the acquisition

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation All-share acquisition positions Inspira to expand into a multi-billion dollar diagnostics market with a development-ready innovative technology; transaction structured to include significant protections for existing shareholders of Inspira relating